Importance Cardiogenic shock affects between 40 000 and 50 000 people in the US per
year and is the leading cause of in-hospital mortality following acute myocardial infarction …

Cardiogenic shock (CS) remains the most common cause of death in patients admitted with
acute myocardial infarction (AMI) and mortality remained nearly unchanged in the range of …

Background Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly
used in patients with cardiogenic shock despite the lack of evidence from adequately …

Cardiogenic shock (CS) is a complex multifactorial clinical syndrome with extremely high
mortality, develo** as a continuum, and progressing from the initial insult (underlying …

Acute coronary syndromes (ACS) are a comprehensive disease concept characterized by
acute myocardial ischemia caused by disruption of coronary artery plaque and consequent …

Cardiogenic shock can occur due to acute ischaemic or non-ischaemic cardiac events, or
from progression of long-standing underlying heart disease. When addressing the cause of …

Background: The role of intraaortic balloon counterpulsation (IABP) in cardiogenic shock is
still a subject of intense debate despite the neutral results of the IABP-SHOCK II trial …

Background: Impella was approved for mechanical circulatory support (MCS) in 2008, but
large-scale, real-world data on its use are lacking. Our objective was to describe trends and …

Background There is a lack of contemporary data on cardiogenic shock (CS) in‐hospital
mortality trends. Methods and Results Patients with CS admitted January 1, 2004 to …

Cardiogenic shock accounts for~ 100,000 annual hospital admissions in the United States.
Despite improvements in medical management strategies, in-hospital mortality remains …